Internal Medicine, Hematology & Oncology · Port Jefferson Station, NY
NPI
1750585287
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
49 Nesconset Hwy
Port Jefferson Station, NY, 11776
Phone (631) 751-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.3M
241,337 services
Medicare patients, 2024
2,630
Average age 75
Drug cost, 2024
$8.5M
2,505 prescriptions
Company payments, 2025
$15.22
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David T Chu was code J1439 (injection, ferric carboxymaltose, 1 mg), 84,001 times for 100 patients. In total David T Chu billed 241,337 services in 286 codes, and Medicare paid $3.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 84,001 | 100 | $0.87 | $73K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 14,401 | 21 | $2.27 | $33K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 13,400 | 27 | $44.56 | $597K |
| J1756 Injection, iron sucrose, 1 mg | Office | 8,401 | 36 | $0.18 | $1,504 |
| 88185 Surgical Pathology Examination | Office | 8,060 | 309 | $21.99 | $177K |
| J0897 Injection, denosumab, 1 mg | Office | 7,680 | 61 | $20.62 | $158K |
| J9267 Injection, paclitaxel, 1 mg | Office | 6,114 | 11 | $0.08 | $486 |
| 36415 Venipuncture Blood Collection | Office | 4,185 | 2,023 | $8.64 | $36K |
| 85025 Blood Count | Office | 4,088 | 1,974 | $7.59 | $31K |
| 80053 Clinical Chemistry | Office | 3,556 | 1,815 | $10.32 | $37K |
| 84100 Clinical Chemistry | Office | 3,243 | 1,645 | $4.63 | $15K |
| 83735 Clinical Chemistry | Office | 3,179 | 1,596 | $6.55 | $21K |
| 84550 Clinical Chemistry | Office | 3,158 | 1,575 | $4.41 | $14K |
| 83615 Clinical Chemistry | Office | 3,111 | 1,560 | $5.90 | $18K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 3,090 | 13 | $37.14 | $115K |
By year: 2022 $6.1M for 511,309 services; 2023 $4.3M for 323,812 services; 2024 $3.3M for 241,337 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88185 Surgical Pathology Examination | 8,060 | 309 | $21.99 | $177K |
| 36415 Venipuncture Blood Collection | 4,185 | 2,023 | $8.64 | $36K |
| 85025 Blood Count | 4,088 | 1,974 | $7.59 | $31K |
| 80053 Clinical Chemistry | 3,556 | 1,815 | $10.32 | $37K |
| 84100 Clinical Chemistry | 3,243 | 1,645 | $4.63 | $15K |
| 83735 Clinical Chemistry | 3,179 | 1,596 | $6.55 | $21K |
| 84550 Clinical Chemistry | 3,158 | 1,575 | $4.41 | $14K |
| 83615 Clinical Chemistry | 3,111 | 1,560 | $5.90 | $18K |
| 82728 Clinical Chemistry | 2,790 | 1,431 | $13.33 | $37K |
| 83540 Clinical Chemistry | 2,765 | 1,407 | $6.32 | $17K |
Medicare prescription drug claims, 2024
In 2024, the drug David T Chu prescribed most often to Medicare patients was Aranesp (Darbepoetin Alfa In Polysorbat), with 237 prescriptions and refills. In total David T Chu wrote 2,505 Medicare prescriptions that cost $8.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Aranesp Darbepoetin Alfa In Polysorbat | 237 | 237 | 50 | $709K |
| Xarelto Rivaroxaban | 188 | 402 | 55 | $222K |
| Eliquis Apixaban | 162 | 253 | 39 | $146K |
| Anastrozole Generic | 147 | 342 | 40 | $2,178 |
| Prednisone Generic | 98 | 99 | 38 | $400 |
| Akynzeo Fosnetupitant/Palonosetron | 89 | 90 | 25 | $122K |
| Omeprazole Generic | 57 | 81 | 13 | $421 |
| Ondansetron Odt Ondansetron | 54 | 54 | 44 | $661 |
| Imbruvica Ibrutinib | 46 | 46 | Under 11 | $707K |
| Somatuline Depot Lanreotide Acetate | 40 | 40 | Under 11 | $366K |
| Xgeva Denosumab | 40 | 50 | 13 | $123K |
| Procrit Epoetin Alfa | 39 | 39 | Under 11 | $54K |
| Oxycodone Hcl Generic | 36 | 36 | 17 | $552 |
| Lupron Depot Leuprolide Acetate | 35 | 77 | Under 11 | $152K |
| Abiraterone Acetate Generic | 34 | 34 | Under 11 | $57K |
Brand drugs: 1,381 claims; generic drugs: - claims; opioid claims: 73.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David T Chu $15.22 ($15.22 in general payments such as food, travel and fees) from 1 company. The largest payer was Alnylam Pharmaceuticals Inc. with $15.22.
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. ALNY | 1 | $15.22 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.